2017
DOI: 10.1186/s12944-017-0628-x
|View full text |Cite
|
Sign up to set email alerts
|

Combination of berberine and evodiamine inhibits intestinal cholesterol absorption in high fat diet induced hyperlipidemic rats

Abstract: BackgroundHyperlipidemia characterized of elevated serum lipid levels is a prevalent disease frequently resulting in cardiovascular disease (CVD). Berberine and evodiamine are herbal products of traditional Chinese herb Coptis chinensis and Evodia rutaecarpa, which are indicated to exert regulation of lipid metabolism. Therefore, the objective of this study was to investigate the lipid-lowering effect of berberine and evodiamine combination in hyperlipidemic rats.MethodThe rat model of hyperlipidemia was estab… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

3
26
0

Year Published

2018
2018
2021
2021

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 46 publications
(30 citation statements)
references
References 41 publications
3
26
0
Order By: Relevance
“…Furthermore, it is well-known that the absorption of cholesterol in the intestine is also a critical process in lipid homeostasis, and that ACAT2 is a key enzyme for modulating the intestinal absorption of cholesterol [29]. As shown in Figure 6, ACAT2 protein expression is upregulated in HF diet-fed rats, which can be reversed by the supplementation of 5% HC and 5% LC, but not 5% CO. Zhou et al (2017) have discovered the cholesterol-lowering activity of the co-administration of berberine and evodiamine supplementation by the inhibition of ACAT2 protein expression [30], which is also consistent with our findings in the present study. Effects of high-molecular weight and low-molecular weight (MW) chitosan or chitosan oligosaccharide on hepatic (AMP)-activated protein kinase-α (AMPKα) and peroxisome proliferator-activated receptor-α (PPARα) protein expressions and low-density lipoprotein receptor (LDLR) and cholesterol 7α-hydroxylase (CYP7A1) gene expressions in high-fat (HF) diet-fed rats.…”
Section: The Mechanism Of Hc Lc and Co In The Livers And Intestinessupporting
confidence: 93%
“…Furthermore, it is well-known that the absorption of cholesterol in the intestine is also a critical process in lipid homeostasis, and that ACAT2 is a key enzyme for modulating the intestinal absorption of cholesterol [29]. As shown in Figure 6, ACAT2 protein expression is upregulated in HF diet-fed rats, which can be reversed by the supplementation of 5% HC and 5% LC, but not 5% CO. Zhou et al (2017) have discovered the cholesterol-lowering activity of the co-administration of berberine and evodiamine supplementation by the inhibition of ACAT2 protein expression [30], which is also consistent with our findings in the present study. Effects of high-molecular weight and low-molecular weight (MW) chitosan or chitosan oligosaccharide on hepatic (AMP)-activated protein kinase-α (AMPKα) and peroxisome proliferator-activated receptor-α (PPARα) protein expressions and low-density lipoprotein receptor (LDLR) and cholesterol 7α-hydroxylase (CYP7A1) gene expressions in high-fat (HF) diet-fed rats.…”
Section: The Mechanism Of Hc Lc and Co In The Livers And Intestinessupporting
confidence: 93%
“…Zhou et al [77] studied the combination of berberine (72.6 mg/kg p.o.) and evodiamine (16.6 mg/kg p.o.)…”
Section: From Drug Combination To Structural Linkage With Other Bioacmentioning
confidence: 99%
“…Among the identified compounds, β-sitosterol is reported to have pharmacological activities, including antihyperlipidemia, anti-inflammation and antitumor. [17][18][19][20][21] Moreover, β-sitosterol showed positive effect on endothelial cell migration. [22] Aristolone possessed radical scavenging activity, [23] and α-amyrin induced proliferation of human keratinocytes.…”
Section: Identification Of Chemical Components From Patrinia Scabiosimentioning
confidence: 99%